The Centers for Disease Control and Prevention, the U.S. Food and Drug Administration (FDA), and state and local health departments are investigating a multistate outbreak of severe e-cigarette or vaping product use-associated lung injury (EVALI).
State of Texas
Note: These numbers are updated as of Nov. 15, 2019 and will be updated weekly.
Confirmed cases meet all of the following criteria:
Using an e-cigarette or dabbing within 90 days prior to symptom onset
Pulmonary infiltrate on plain film chest radiograph or ground-glass opacities on chest CT
Absence of pulmonary infection on initial work-up
No evidence in the patient’s medical records of alternative plausible diagnoses
For additional resources geared toward youth visit CATCH My Breath, a best practices youth e-cigarette and JUUL prevention program develop by UT Health, or ASPIRE, an evidence-based program developed by MD Anderson.
Members of the media can direct their questions to Anna Lassmann.